Recombinant human C1 esterase inhibitor (Conestat alfa) for prophylaxis to prevent attacks in adult and adolescent patients with hereditary angioedema
Sign Up to like & getrecommendations! Published in 2018 at "Expert Review of Clinical Immunology"
DOI: 10.1080/1744666x.2018.1503055
Abstract: ABSTRACT Introduction: Hereditary angioedema (HAE) due to C1 inhibitor (C1-INH) deficiency is a debilitating and potentially lethal disease. Management includes on-demand treatment of angioedema and their prophylaxis. Plasma derived C1-INH is an established treatment for… read more here.
Keywords: treatment; prophylaxis; conestat alfa; rhc1 inh ... See more keywords
Recombinant human C1 esterase inhibitor for acute hereditary angioedema attacks with upper airway involvement.
Sign Up to like & getrecommendations! Published in 2017 at "Allergy and asthma proceedings"
DOI: 10.2500/aap.2017.38.4090
Abstract: BACKGROUND Recombinant human C1 esterase inhibitor (rhC1-INH) is approved for treatment of hereditary angioedema (HAE) in adolescents and adults. HAE attacks that involve the upper airway can be life threatening, and data on the administration… read more here.
Keywords: airway involvement; attacks upper; treatment; upper airway ... See more keywords